End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
7.84
CNY
|
+1.42%
|
|
+0.51%
|
-6.67%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
4,290
|
7,478
|
8,434
|
11,651
|
9,391
|
6,303
|
6,303
|
-
|
Enterprise Value (EV)
1 |
4,290
|
7,172
|
8,170
|
11,882
|
9,974
|
6,741
|
7,306
|
7,302
|
P/E ratio
|
22.4
x
|
35.9
x
|
36.8
x
|
46.1
x
|
37.1
x
|
23.3
x
|
18.8
x
|
15.3
x
|
Yield
|
-
|
0.84%
|
0.82%
|
0.65%
|
0.95%
|
1.45%
|
1.87%
|
2.2%
|
Capitalization / Revenue
|
4.58
x
|
6.75
x
|
5.76
x
|
5.26
x
|
3.87
x
|
2.54
x
|
1.95
x
|
1.67
x
|
EV / Revenue
|
4.58
x
|
6.48
x
|
5.58
x
|
5.36
x
|
4.11
x
|
2.54
x
|
2.26
x
|
1.93
x
|
EV / EBITDA
|
15.8
x
|
22.5
x
|
20.6
x
|
23.5
x
|
17.2
x
|
13.4
x
|
10.4
x
|
9.25
x
|
EV / FCF
|
-
|
-75,573,414
x
|
-
|
1,211,420,562
x
|
-174,767,170
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-
|
0%
|
-0%
|
-
|
-
|
-
|
Price to Book
|
3.67
x
|
5.95
x
|
6.13
x
|
7.38
x
|
5.29
x
|
3.53
x
|
2.86
x
|
2.51
x
|
Nbr of stocks (in thousands)
|
796,858
|
796,858
|
796,858
|
796,858
|
800,819
|
803,929
|
803,929
|
-
|
Reference price
2 |
5.384
|
9.385
|
10.58
|
14.62
|
11.73
|
7.840
|
7.840
|
7.840
|
Announcement Date
|
1/8/19
|
1/21/20
|
1/18/21
|
1/11/22
|
1/15/23
|
1/16/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
937.3
|
1,107
|
1,465
|
2,217
|
2,428
|
2,659
|
3,236
|
3,782
|
EBITDA
1 |
272.2
|
319.3
|
395.7
|
504.6
|
580.9
|
537.1
|
704.7
|
789.6
|
EBIT
1 |
225.9
|
262.3
|
307
|
389.5
|
348.2
|
384.6
|
510
|
600.5
|
Operating Margin
|
24.1%
|
23.69%
|
20.96%
|
17.57%
|
14.34%
|
14.47%
|
15.76%
|
15.88%
|
Earnings before Tax (EBT)
1 |
237.6
|
273
|
322
|
400.1
|
371.2
|
398.5
|
500.8
|
616
|
Net income
1 |
191.2
|
208.4
|
229.3
|
252.7
|
252.9
|
255.5
|
350.4
|
431.8
|
Net margin
|
20.39%
|
18.82%
|
15.65%
|
11.4%
|
10.42%
|
9.61%
|
10.83%
|
11.42%
|
EPS
2 |
0.2399
|
0.2615
|
0.2877
|
0.3171
|
0.3157
|
0.3367
|
0.4172
|
0.5130
|
Free Cash Flow
|
-
|
-94.9
|
-
|
9.808
|
-57.07
|
-
|
-
|
-
|
FCF margin
|
-
|
-8.57%
|
-
|
0.44%
|
-2.35%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
1.94%
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
3.88%
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.0785
|
0.0871
|
0.0954
|
0.1109
|
0.1138
|
0.1468
|
0.1728
|
Announcement Date
|
1/8/19
|
1/21/20
|
1/18/21
|
1/11/22
|
1/15/23
|
1/16/24
|
-
|
-
|
Fiscal Period: December |
2019 S1
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
454.2
|
408.4
|
475.6
|
603.6
|
940
|
468.4
|
536.1
|
595.2
|
1,059
|
507.4
|
1,184
|
845.7
|
845.7
|
EBITDA
1 |
-
|
-
|
73.32
|
130.4
|
-
|
-
|
-
|
-
|
333
|
140.2
|
242.2
|
191.2
|
191.2
|
EBIT
1 |
-
|
-36.12
|
56.16
|
83.66
|
244.5
|
-32.01
|
63.77
|
57.15
|
295.7
|
76.5
|
178.5
|
127.5
|
127.5
|
Operating Margin
|
-
|
-8.84%
|
11.81%
|
13.86%
|
26.01%
|
-6.83%
|
11.89%
|
9.6%
|
27.93%
|
15.08%
|
15.08%
|
15.08%
|
15.08%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.1478
|
-0.0352
|
0.0628
|
0.0818
|
0.2196
|
-0.0301
|
0.0649
|
0.0600
|
0.2050
|
0.0606
|
0.1414
|
0.1010
|
0.1010
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.1045
|
-
|
-
|
-
|
0.1422
|
Announcement Date
|
7/10/19
|
4/27/22
|
8/25/22
|
10/25/22
|
1/15/23
|
4/27/23
|
8/30/23
|
10/30/23
|
1/16/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
231
|
583
|
876
|
1,004
|
999
|
Net Cash position
1 |
-
|
306
|
265
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.4579
x
|
1.004
x
|
1.631
x
|
1.424
x
|
1.266
x
|
Free Cash Flow
|
-
|
-94.9
|
-
|
9.81
|
-57.1
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
17.5%
|
16.5%
|
17.1%
|
17.2%
|
15.2%
|
13.9%
|
15.6%
|
16.9%
|
ROA (Net income/ Total Assets)
|
-
|
11.9%
|
10.7%
|
8.09%
|
9.03%
|
5.43%
|
6.6%
|
7.4%
|
Assets
1 |
-
|
1,755
|
2,140
|
3,122
|
2,800
|
4,710
|
5,310
|
5,836
|
Book Value Per Share
2 |
1.470
|
1.580
|
1.730
|
1.980
|
2.220
|
2.380
|
2.740
|
3.130
|
Cash Flow per Share
2 |
0.3100
|
0.2500
|
0.4300
|
0.4900
|
0.3400
|
0.7400
|
0.5700
|
0.9300
|
Capex
1 |
108
|
297
|
347
|
378
|
333
|
313
|
506
|
423
|
Capex / Sales
|
11.49%
|
26.82%
|
23.68%
|
17.07%
|
13.73%
|
11.74%
|
15.65%
|
11.19%
|
Announcement Date
|
1/8/19
|
1/21/20
|
1/18/21
|
1/11/22
|
1/15/23
|
1/16/24
|
-
|
-
|
Last Close Price
7.84
CNY Average target price
12.51
CNY Spread / Average Target +59.57% Consensus |
1st Jan change
|
Capi.
|
---|
| -6.67% | 870M | | +14.61% | 17.2B | | 0.00% | 6.8B | | -12.39% | 2.88B | | -11.15% | 2.72B | | -31.21% | 1.74B | | +5.00% | 1.25B | | -7.31% | 1.06B | | -4.08% | 794M | | +0.62% | 757M |
Testing Laboratories
|